PrintFriendly
Featured News
|
Monday, July 22, 2019  The applications are for the company's investigational gene therapy candidate for adults with hemophilia A. |
|
Monday, July 22, 2019  The data presented at ISTH reflected marked improvements in FVIII half-life amongst study participants. |
|
Friday, July 19, 2019  Bayer has announced a recall of two lots of Kogenate® FS 2000 IU vials. |
|
Thursday, July 18, 2019  uniQure's gene therapy candidate AMT-061 is being developed for individuals with severe and moderately severe hemophilia B. |
|
Thursday, July 11, 2019  The final data was presented for the first time at a symposium at the XXVII Congress of the International Society on Thrombosis and Haemostasis (ISTH). |
|
Thursday, July 11, 2019  Much of the data was gleaned from the HAVEN clinical trial program. |
|
Tuesday, July 9, 2019  The findings presented at ISTH were based on an ongoing phase 1/2 clinical trial in patients with severe hemophilia A. |
|
Tuesday, July 9, 2019  NHF's Connections for Learning program brings families education and support. |
|
Tuesday, July 9, 2019  Protections for pre-existing conditions and coverage standards at risk |
|
Tuesday, July 2, 2019  The findings of a new study suggest several areas of impact relevant to adherence and physical activity for patients with severe hemophilia A. |